Factors affecting engraftment and hematopoietic recovery after unpurged autografting in acute leukemia

Bone Marrow Transplantation

Volumn 18, Issue 2, 1996, Pages 319-324

  Mehta, J ^a   Powles, R ^a   Horton, C ^a   Treleaven, J ^a   Singhal, S ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Autologous transplantation; Bone marrow; Engraftment; Graft failure; Nucleated cell dose; Peripheral blood stem cells

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CHILD; CRYOPRESERVATION; FEMALE; HEMATOPOIESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029790774     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Stewart P, Buckner CD, Bensinger W et al. Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remission. Exp Hematol 1985; 13: 267-272.
2. Chopra R, Goldstone AH, McMillan AK et al. Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience. J Clin Oncol 1991; 9: 1840-1847.
3. Petersen FB, Lynch MHE, Clift RA et al. Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission. J Clin Oncol 1993; 11: 1353-1360.
4. Powles R, Mehta J, Singhal S et al. Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center. Bone Marrow Transplant 1995; 16: 241-247.
5. Mehta J, Powles R, Singhal S et al. Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factors. Bone Marrow Transplant 1995; 16: 499-506.
6. Mehta J, Powles R, Singhal S et al. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission. Bone Marrow Transplant 1996; 18: 119-123.
7. Yeager AM, Kaizer H, Santos GW et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. New Engl J Med 1986; 315: 141-147.
8. Gorin NC, Labopin M, Meloni G et al. Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT). Leukemia 1991; 5: 896-904.
9. Klingemann HG, Eaves CJ, Barnett MJ et al. Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administration. Bone Marrow Transplant 1994; 14: 389-396.
10. Mehta J, Powles R, Singhal S et al. Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia. Bone Marrow Transplant (submitted).
11. Juttner CA, To LB, Haylock DN et al. Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. Br J Haematol 1985; 61: 739-745.
12. Körbling M, Fliedner TM, Holle R et al. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival. Bone Marrow Transplant 1991; 7: 343-349.
13. Sanz MA, De la Rubia J, Sanz GF et al. Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution. J Clin Oncol 1993; 11: 1661-1667.
14. Mehta J, Powles R, Singhal S, Treleaven J. Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukaemia due to reinfusion of a higher number of malignant cells. Bone Marrow Transplant 1995; 15: 652-653.
15. Demirer T, Buckner CD, Appelbaum FR et al. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Bone Marrow Transplant 1995; 15: 915-922.
16. Mehta J, Powles RL, Shepherd V et al. Transplantation of autologous peripheral blood stem cells mobilized using GM-CSF for acute leukemia with myelofibrosis. Leuk Lymphoma 1993; 11: 157-158.
17. Mehta J, Powles R, Singhal S et al. Outcome of autologous rescue after failed engraftment of allogeneic marrow. Bone Marrow Transplant 1996; 17: 213-217.
18. Mehta J, Powles R, Singhal S et al. Sequential high-dose therapy of adult acute lymphoblastic leukemia: role of maintenance chemotherapy after peripheral blood stem cell transplantation in first remission. In: Dicke KA, Keating A (eds). Autologous Marrow and Blood Transplantation: Proceedings of the Seventh International Symposium, Arlington, Texas. The Cancer Treatment Research and Educational Institute: Arlington, 1995, pp 135-144.
19. Mehta J, Powles R, Singhal S et al. Peripheral blood stem cell autografts for acute lymphoblastic leukemia: effect of G-CSF dose and harvest schedule on cell yields. Br J Haematol 1995; 89(Suppl. 1): 19.
20. Mehta J, Powles R, Cabral S et al. Comparison of Cobe Spectra and Haemonetics MCS-3P cell separators for harvesting peripheral blood stem cells. Bone Marrow Transplant 1995; 16: 707-709.
21. De La Rubia J, Sanz GF, Martínez J et al. Autologous blood stem cell transplantation in acute myeloblastic leukemia in first remission. Blood 1994; 84 (Suppl. 1): 213a.
22. Dreger P, Klöss M, Petersen B et al. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995; 86: 3970-3978.
23. Laporte JP, Gorin NC, Feuchtenbaum J et al. Relapse after autografting with peripheral blood stem cells. Lancet 1987; 2: 1393.
24. Demirer T, Bensinger WI, Rowley S et al. Comparison of granulocyte-colony stimulating factor (rhG-CSF) mobilized peripheral blood stem cells (PBSC) and bone marrow for autologous transplantation in patients with acute myelogenous leukemia (AML). Blood 1995; 86 (Suppl. 1): 99a.
25. Reiffers J, Körbling M, Labopin M et al. Autologous blood stem cell transplantation versus autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. Int J Cell Clon 1992; 10: 111-113.
26. Schiller G, Mittal-Henkle A, Lill M et al. Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine/G-CSF based consolidation for adults with acute myelogenous leukemia in first remission. Blood 1995; 86 (Suppl. 1): 99a.
27. Demirer T, Gooley T, Buckner CD et al. Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation. Bone Marrow Transplant 1995; 15: 907-913.
28. Burnett AK, Goldstone AH, Stevens RF et al. The role of BMT in addition to intensive chemotherapy in AML in first CR: results of the MRC AML-10 trials. Blood 1994; 84 (Suppl. 1): 252a.
29. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl J Med 1995; 332: 217-223.
30. Gisselbrecht C, Prentice HG, Bacigalupo A et al. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation. Lancet 1994; 343: 696-700 (Erratum: Lancet 1994; 343: 804).